Literature DB >> 33557115

Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease.

Candida Manelfi1, Jonas Gossen2,3, Silvia Gervasoni4, Carmine Talarico1, Simone Albani2,3, Benjamin Joseph Philipp2,3, Francesco Musiani5, Giulio Vistoli4, Giulia Rossetti2,6,7, Andrea Rosario Beccari1, Alessandro Pedretti4.   

Abstract

The 3CL-Protease appears to be a very promising medicinal target to develop anti-SARS-CoV-2 agents. The availability of resolved structures allows structure-based computational approaches to be carried out even though the lack of known inhibitors prevents a proper validation of the performed simulations. The innovative idea of the study is to exploit known inhibitors of SARS-CoV 3CL-Pro as a training set to perform and validate multiple virtual screening campaigns. Docking simulations using four different programs (Fred, Glide, LiGen, and PLANTS) were performed investigating the role of both multiple binding modes (by binding space) and multiple isomers/states (by developing the corresponding isomeric space). The computed docking scores were used to develop consensus models, which allow an in-depth comparison of the resulting performances. On average, the reached performances revealed the different sensitivity to isomeric differences and multiple binding modes between the four docking engines. In detail, Glide and LiGen are the tools that best benefit from isomeric and binding space, respectively, while Fred is the most insensitive program. The obtained results emphasize the fruitful role of combining various docking tools to optimize the predictive performances. Taken together, the performed simulations allowed the rational development of highly performing virtual screening workflows, which could be further optimized by considering different 3CL-Pro structures and, more importantly, by including true SARS-CoV-2 3CL-Pro inhibitors (as learning set) when available.

Entities:  

Keywords:  3CL-Pro; SARS-CoV-2; antivirals; binding space; consensus models; docking simulations; drug repurposing; isomeric space; virtual screening

Mesh:

Substances:

Year:  2021        PMID: 33557115      PMCID: PMC7913849          DOI: 10.3390/molecules26040797

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  48 in total

1.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins.

Authors:  Edward Harder; Wolfgang Damm; Jon Maple; Chuanjie Wu; Mark Reboul; Jin Yu Xiang; Lingle Wang; Dmitry Lupyan; Markus K Dahlgren; Jennifer L Knight; Joseph W Kaus; David S Cerutti; Goran Krilov; William L Jorgensen; Robert Abel; Richard A Friesner
Journal:  J Chem Theory Comput       Date:  2015-12-01       Impact factor: 6.006

2.  FRED pose prediction and virtual screening accuracy.

Authors:  Mark McGann
Journal:  J Chem Inf Model       Date:  2011-02-16       Impact factor: 4.956

3.  Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding: A MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program.

Authors:  Alessandro Pedretti; Cinzia Granito; Angelica Mazzolari; Giulio Vistoli
Journal:  Mol Inform       Date:  2016-07-14       Impact factor: 3.353

4.  Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database.

Authors:  Paul C D Hawkins; A Geoffrey Skillman; Gregory L Warren; Benjamin A Ellingson; Matthew T Stahl
Journal:  J Chem Inf Model       Date:  2010-04-26       Impact factor: 4.956

5.  Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses.

Authors:  Chi-Pang Chuck; Hak-Fun Chow; David Chi-Cheong Wan; Kam-Bo Wong
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

6.  A novel coronavirus outbreak of global health concern.

Authors:  Chen Wang; Peter W Horby; Frederick G Hayden; George F Gao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays.

Authors:  Angelica Mazzolari; Silvia Gervasoni; Alessandro Pedretti; Laura Fumagalli; Rosanna Matucci; Giulio Vistoli
Journal:  Int J Mol Sci       Date:  2020-08-19       Impact factor: 5.923

8.  Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors.

Authors:  Wei-Chung Chiou; Meng-Shiuan Hsu; Yun-Ti Chen; Jinn-Moon Yang; Yeou-Guang Tsay; Hsiu-Chen Huang; Cheng Huang
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

9.  Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2.

Authors:  Yue Zhu; De-Yu Xie
Journal:  Front Plant Sci       Date:  2020-11-30       Impact factor: 5.753

Review 10.  Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks.

Authors:  Hossam M Ashour; Walid F Elkhatib; Md Masudur Rahman; Hatem A Elshabrawy
Journal:  Pathogens       Date:  2020-03-04
View more
  7 in total

Review 1.  Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

Authors:  Kaifu Gao; Rui Wang; Jiahui Chen; Limei Cheng; Jaclyn Frishcosy; Yuta Huzumi; Yuchi Qiu; Tom Schluckbier; Xiaoqi Wei; Guo-Wei Wei
Journal:  Chem Rev       Date:  2022-05-20       Impact factor: 72.087

2.  Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants.

Authors:  Daniela Iaconis; Licia Bordi; Giulia Matusali; Carmine Talarico; Candida Manelfi; Maria Candida Cesta; Mara Zippoli; Francesca Caccuri; Antonella Bugatti; Alberto Zani; Federica Filippini; Laura Scorzolini; Marco Gobbi; Marten Beeg; Arianna Piotti; Monica Montopoli; Veronica Cocetta; Silvia Bressan; Enrico M Bucci; Arnaldo Caruso; Emanuele Nicastri; Marcello Allegretti; Andrea R Beccari
Journal:  Cell Death Dis       Date:  2022-05-25       Impact factor: 9.685

Review 3.  Virus structure and structure-based antivirals.

Authors:  Zlatka Plavec; Ina Pöhner; Antti Poso; Sarah J Butcher
Journal:  Curr Opin Virol       Date:  2021-09-24       Impact factor: 7.121

4.  Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities.

Authors:  Angela Corona; Krzysztof Wycisk; Carmine Talarico; Candida Manelfi; Jessica Milia; Rolando Cannalire; Francesca Esposito; Philip Gribbon; Andrea Zaliani; Daniela Iaconis; Andrea R Beccari; Vincenzo Summa; Marcin Nowotny; Enzo Tramontano
Journal:  ACS Pharmacol Transl Sci       Date:  2022-04-01

5.  Extensive Sampling of Molecular Dynamics Simulations to Identify Reliable Protein Structures for Optimized Virtual Screening Studies: The Case of the hTRPM8 Channel.

Authors:  Silvia Gervasoni; Carmine Talarico; Candida Manelfi; Alessandro Pedretti; Giulio Vistoli; Andrea R Beccari
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

6.  Exscalate4CoV: Innovative High Performing Computing (HPC) Strategies to Tackle Pandemic Crisis.

Authors:  Andrea R Beccari; Giulio Vistoli
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

7.  Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics.

Authors:  Marco Tutone; Anna Maria Almerico
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.